Infinium Global Research and Consulting Solutions

The United States hemostats and tissue sealants market was valued at USD 1,841.7 million in 2022 and is expected to reach USD 3,429.7 million by 2030 and grow at a CAGR of 8.21% over the forecast period. The prevalence of cardiovascular diseases in the United States drives the market growth. Cardiovascular diseases are of several types that involve Coronary Heart Disease (CHD), stroke, heart failure, and other conditions affecting the heart and blood vessels. According to a report by the New York State Department of Health in 2022, every year about 697,000 people die of heart disease in the United States. The increasing number of patients suffering from several types of heart-related diseases is boosting the number of surgeries performed to treat them. Additionally, hemostats and tissue sealants are used to seal incisions in bowel surgeries, hernia repair surgeries, Hysterectomies, appendectomies, and gallbladder removal surgeries. The rising number of general surgeries is likely to promote the growth of the market in the United States. Moreover, modern plastic surgery has become increasingly popular in the United States which contributes to the expansion of the market in the United States. However, the adverse reaction associated with the use of hemostats and tissue sealants, such as foreign body reactions, inflammation, and infections hampers the growth of the market. Although, new product development combined with mergers and acquisitions provides lucrative growth opportunities for the market.